Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing for stroke intervention
Debarati Ghosh, Karan Sehgal, Babasaheb Sodnar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1974-1982
Closed Access | Times Cited: 19

Showing 19 citing articles:

Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones
Maryam Adenike Salaudeen, Nura Bello, Rabi’u Nuhu Danraka, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 305-305
Open Access | Times Cited: 26
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 39
The D-Dimer/Albumin Ratio as a Novel Biomarker for Predicting the Efficacy of Oral Tirofiban in Patients with Cerebral Infarction
Xiaohui Li, Huimin Guo, Caixia Guo, et al.
Clinical and Applied Thrombosis/Hemostasis (2025) Vol. 31
Open Access
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
Paul Perco, Matthias Ley, Kinga Kęska‐Izworska, et al.
PROTEOMICS (2025)
Open Access
Complementary therapies for stroke towards neurorecovery
Anirban Barik, Chetsi Shah, Gautam Karmarkar, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Inosine attenuates post-stroke neuroinflammation by modulating inflammasome mediated microglial activation and polarization
Aishika Datta, Pramod Suthar, Deepaneeta Sarmah, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166771-166771
Closed Access | Times Cited: 9
Engineered extracellular vesicles for ischemic stroke: a systematic review and meta-analysis of preclinical studies
Pengtao Li, Rui Yin, Yi‐Hao Chen, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction
Ingrid M. Heyns, Alina Farah Faunce, Mercy Ngosa Mumba, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2237-2250
Open Access | Times Cited: 2
Role of blood–brain barrier dysfunction in the development of poststroke epilepsy
Wouter C. Meijer, Jan A. Gorter
Epilepsia (2024) Vol. 65, Iss. 9, pp. 2519-2536
Open Access | Times Cited: 2
Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?
Yuying Guo, Dongsheng Hu, Lu Lian, et al.
Stem Cell Reviews and Reports (2022) Vol. 19, Iss. 2, pp. 285-308
Closed Access | Times Cited: 12
Research progress on the role of hormones in ischemic stroke
Shu-Yuan Huang, Lu Liu, Xiaodong Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
New Perspectives for Antihypertensive Sartans as Components of Co-crystals and Co-amorphous Solids with Improved Properties and Multipurpose Activity
Marika Turek, Ewa Różycka‐Sokołowska, Krzysztof Owsianik, et al.
Molecular Pharmaceutics (2023) Vol. 21, Iss. 1, pp. 18-37
Closed Access | Times Cited: 4
Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke
Kai Jing, Ruinan Gu, Feng Chen, et al.
Pharmacological Research (2024) Vol. 209, pp. 107422-107422
Open Access | Times Cited: 1
Exploring DrugCentral: from molecular structures to clinical effects
Liliana Halip, Sorin Avram, Ramona Curpăn, et al.
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 12, pp. 681-694
Open Access | Times Cited: 3
BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
Majid Mokhtari, Samane Khoshbakht, Mohammad Esmaeil Akbari, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Pharmacotherapy for post-stroke aphasia: what are the options?
Marcelo L. Berthier, Guadalupe Dávila
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 11, pp. 1221-1228
Closed Access | Times Cited: 2
Treatment of Stroke at a Delayed Timepoint with a Repurposed Drug Targeting Sigma 1 Receptors
Derek A. Schreihofer, Dhwanil A. Dalwadi, Seongcheol Kim, et al.
Translational Stroke Research (2023) Vol. 15, Iss. 6, pp. 1035-1049
Closed Access | Times Cited: 2
Repurposing of Oxicam Derivatives to Inhibit NDM-1: Molecular Docking and Molecular Dynamic Simulation Studies
Pshtiwan G. Ali, Twana Salih
Al Mustansiriyah Journal of Pharmaceutical Sciences (2024) Vol. 24, Iss. 4, pp. 343-360
Open Access
Heat‐shock protein A12A attenuates oxygen‐glucose deprivation/reoxygenation‐induced human brain microvascular endothelial cell dysfunction via PGC‐1α/SIRT3 pathway
Jun Li, Shouyin Shen, Haiyan Shen
Drug Development Research (2023) Vol. 85, Iss. 1
Closed Access | Times Cited: 1
Page 1

Scroll to top